Picture of Silk Road Medical logo

SILK — Silk Road Medical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Silk Road Medical Inc reports results for the quarter ended in September - Earnings Summary

* Silk Road Medical Inc  SILK.OQ  reported a quarterly
adjusted
loss of 29 cents​​ per share for the quarter ended in September.
The mean expectation of six analysts for the quarter was for a
loss of 43 cents per share.
    * Revenue rose 51.3% to $37.37 million from a year ago;
analysts
expected $33.64 million. 
    * Silk Road Medical Inc's reported EPS for the quarter was a
loss
of 29 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Silk Road Medical Inc shares had fallen by 6.4% this
quarter and
lost 1.1% so far this year.
    * The company reported a quarterly loss of $10.32 million.
    * Wall Street's median 12-month price target for Silk Road
Medical
Inc is $45.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
8 at 11:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.43          -0.29          Beat
 Jun. 30 2022      -0.46          -0.43          Beat
 Mar. 31 2022      -0.37          -0.48          Missed
 Dec. 31 2021      -0.36          -0.42          Missed

Recent news on Silk Road Medical

See all news